🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Australia / NCT04642807
Recruiting Not applicable

Management of Type 1 Supracondylar Humeral Fractures

NCT04642807 · tracked via the Priya Life Science Australia tracker
Phase
Not applicable
Started
2021-04-01
Last updated
2024-12-11

Condition(s) studied

Elbow FractureTrauma

Investigational drug(s) / intervention(s)

Long arm soft castLong arm full cast

Long arm soft cast: Participants in group 2 will have a long arm soft cast applied without clinical or radiological follow up.

Long arm full cast: Participants in group 1 will have a long arm full cast applied.

Study summary

This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up.

This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.

Eligibility

Sex
ALL
Min age
3 Years
Max age
8 Years
Healthy volunteers
Accepted
Inclusion Criteria: \- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced). Exclusion Criteria: * Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury * Children who present with neurovascular compromise associated with their fracture * Children who have been previously diagnosed with a metabolic or structural bone disease that predisposes them to fractures Diagnostic criteria for a Type I supracondylar fracture will include either: A) A clear fracture line through the supracondylar region with no displacement or angulation of the distal humerus (including a normal anterior humeral line that intersects the capitellum) OR B) The absence of a clear fracture line but history of an extension injury to the arm AND tenderness at the elbow AND local swelling AND presence of a posterior fat pad on plain radiographs.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Queensland Children's Hospital, 501 Stanley Street, South Brisbane Australia Recruiting
BC Children's Hospital Vancouver British Columbia Recruiting

More University of British Columbia trials in Australia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04642807 on ClinicalTrials.gov ↗ ← All trials in Australia